Multiple Sclerosis drug Tysabri will be back on shelves

Unison.ie - Bray,Ireland
Irish pharmaceutical company Elan is receiving the go-ahead to put its Multiple Sclerosis drug Tysabri back on the market. The European ...
See all stories on this topic

Biogen Idec (BIIB) and Elan (ELN) Said TYSABRI Receives Approval ...
StreetInsider.com (subscription) - Birmingham,MI,USA
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) said they have received approval from the European Commission to market TYSABRI as a treatment ...

Tysabri Triumphs
LongIslandPress.com - NY,USA
After the deaths of two MS patients taking Tysabri, Biogen Idec Inc. and its partner, Elan, had taken the drug off pharmacy shelves in February 2005. ...
See all stories on this topic

Elan's recovery continues as EU approves Tysabri
MarketWatch - USA
... PLC's (ELN) multiple sclerosis drug Tysabri Thursday received long-awaited approval from the European Commission as a therapy for highly active relapsing ...
See all stories on this topic

Elan's Tysabri EU Ruling Good News - Davy
newratings.com - USA
0748 GMT [Dow Jones] The EU approval of Elan's (ELN) Tysabri is "very good news, with the drug on track as per guidance," says Davy Stockbrokers. ...